AURIS MEDICAL HOLDING AG

Company

Altamira Therapeutics Ltd.

Filed

February 17, 2017

Accession Number

0000902664-17-001277

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →